Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Arup K Roy in Pharmaceutical Formulations
Introduction: Arup K Roy, based in Greenville, NC, is a notable inventor recognized for his work in the pharmaceutical industry. With a strong focus on HIV treatment, Roy's contributions have the potential to impact medical therapy significantly.
Latest Patents: Arup K Roy holds one patent, which details pharmaceutical formulations containing HIV protease inhibitors. This patent includes the formulation of 3S-[3R*(1R*,2S*)]-[3-[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-phenylmethyl)propyl]carbamic acid, tetrahydro-3-furanyl ester, commonly known as VX 478 or 141W94. The patent describes the formulation's applications in medical therapy, underscoring its relevance to HIV treatment.
Career Highlights: Arup K Roy is associated with SmithKline Beecham Corporation, a company well-regarded in the pharmaceutical sector. His work at the corporation showcases his dedication to developing innovative solutions in the field of medicine.
Collaborations: Throughout his career, Roy has collaborated with several professionals, including his coworker, Lloyd G Tillman. Such collaborations not only foster innovation but also enhance the breadth of research and development in pharmaceutical formulations.
Conclusion: Arup K Roy's contributions to pharmaceutical formulations demonstrate the significant role of inventors in advancing medical therapies. His innovative approach, particularly in developing treatment options for HIV, exemplifies the impact that dedicated professionals can have on public health.